BiotechTubeBiotechTube
Home/Pipeline/SHR-1701

SHR-1701

Advanced solid tumors

Phase 1Active

Key Facts

Indication
Advanced solid tumors
Phase
Phase 1
Status
Active
Company
Jiangsu Hengrui Medicine

About Jiangsu Hengrui Medicine

Jiangsu Hengrui Medicine Co., Ltd. is a leading Chinese pharmaceutical company founded in 1970, headquartered in Lianyungang, Jiangsu Province. The company has evolved from producing generic drugs to becoming a major innovator in oncology, with particular strength in developing novel cancer treatments, anesthesia drugs, and medical imaging contrast agents. Hengrui has established itself as one of China's most valuable pharmaceutical companies with significant R&D investments and an expanding global footprint.

View full company profile

Therapeutic Areas

OncologyAnesthesiaContrast ImagingPain ManagementHematology

Other Advanced solid tumors Drugs

DrugCompanyPhase
BAY 1895344BayerPhase 1
HS-10342Hansoh PharmaPhase 1/2
ANKTIVA® + M-ceNKImmunityBioPhase 1
DFTX-101Definium TherapeuticsPhase 1/2
REC-617Recursion PharmaceuticalsPhase 1/2
ZW220ZymeworksPreclinical
NX-1607Nurix TherapeuticsPhase 1a
IMA402 (TCR Bispecific)ImmaticsPhase 1
IMA403 (TCR Bispecific)ImmaticsPre-clinical
BCA101Bicara TherapeuticsPhase 1
AN4005Adlai NortyePreclinical
AN3025Adlai NortyePreclinical